Fideuram Intesa Sanpaolo Private Banking S.P.A. Acquires New Shares in Synopsys, Inc. $SNPS

Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in Synopsys, Inc. (NASDAQ:SNPS) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 7,389 shares of the semiconductor company’s stock, valued at approximately $3,471,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Empirical Asset Management LLC acquired a new stake in Synopsys in the third quarter valued at approximately $773,000. Strategic Advisors LLC lifted its stake in Synopsys by 76.3% in the third quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock valued at $3,739,000 after acquiring an additional 3,279 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its stake in Synopsys by 31.8% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company’s stock valued at $6,957,000 after acquiring an additional 3,575 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Synopsys by 57.7% in the third quarter. Principal Financial Group Inc. now owns 412,766 shares of the semiconductor company’s stock valued at $203,654,000 after acquiring an additional 150,973 shares during the last quarter. Finally, SeaTown Holdings Pte. Ltd. lifted its stake in Synopsys by 55.9% in the fourth quarter. SeaTown Holdings Pte. Ltd. now owns 22,300 shares of the semiconductor company’s stock valued at $10,475,000 after acquiring an additional 8,000 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Morgan Stanley restated an “equal weight” rating and issued a $480.00 price objective (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research note on Friday, February 20th. Finally, Needham & Company LLC restated a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Synopsys has an average rating of “Hold” and a consensus price target of $536.00.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Investor attention has increased after Synopsys posted strong Q1 FY26 results, including roughly 65% year-over-year revenue growth and higher non-GAAP earnings, reinforcing confidence in the company’s growth momentum and updated guidance.
• Positive Sentiment: Analyst coverage remains favorable, with Wall Street’s average brokerage recommendation effectively at “Buy,” which can help support the stock as investors look for confirmation of upside potential.
• Positive Sentiment: Articles highlighting Synopsys as a “trending stock” suggest rising market attention, which can contribute to stronger trading activity and a constructive short-term tone.
• Positive Sentiment: The company’s partnership with Quantinuum adds another growth narrative by tying Synopsys to emerging quantum-computing use cases, expanding the perceived long-term opportunity set.
• Neutral Sentiment: Several recent pieces are mostly valuation and comparison articles, indicating that investors are still debating whether the stock’s premium multiple is justified after its strong run and recent integration progress.
• Negative Sentiment: Some commentary argues Synopsys may be too expensive below $500 and that its AI exposure is not as pure as other semiconductor names, which could cap enthusiasm if valuation concerns return.
• Negative Sentiment: Broader stock-performance commentary noted the shares still underperform the market on a longer horizon, reminding investors that recent gains have not fully erased earlier weakness.

Synopsys Price Performance

Shares of Synopsys stock opened at $498.93 on Thursday. The firm has a fifty day simple moving average of $447.74 and a 200-day simple moving average of $450.22. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a 1-year low of $376.18 and a 1-year high of $651.73. The stock has a market capitalization of $95.58 billion, a price-to-earnings ratio of 77.47, a PEG ratio of 4.03 and a beta of 1.25.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The business had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same period in the previous year, the company earned $3.03 earnings per share. Synopsys’s revenue for the quarter was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.3 earnings per share for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.